Covaxin effective against UK, other Covid-19 variants: Bharat Biotech2 min read . Updated: 03 Mar 2021, 06:26 PM IST
- The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR
- Covaxin is one of the two Covid-19 vaccines approved for emergency use in India for its mega vaccination drive, which started on 16 January, 2021
Bharat Biotech on Wednesday claimed that its Covid-19 vaccine candidate Covaxin shows "significant immunogenicity against the rapidly emerging variants" of Coronavirus.
Select your Category